Saw palmetto extract does not shrink prostate size (redux)

Posted on September 28, 2011 by Sitemaster

Saw palmetto extract (made from the berries of the saw palmetto plant, Serenoa repens) is widely used by many men to prevent or treat benign enlargement of the prostate (benign prostatic hyperplasia). While it is not known to have any effect on prostate cancer, the use of saw palmetto has long been a topic of discussion in the prostate cancer community. … READ MORE …

Filed under: Living with Prostate Cancer, Prevention | Tagged: , , , | 6 Comments »

Prostate cancer, BPH, risk association, and a 3 million man study

Posted on July 14, 2011 by Sitemaster

A commonly raised question is whether men with benign prostatic hyperplasia (BPH) are at greater risk for prostate cancer than men who have no sign of BPH. A new, nation-wide study of the male population of Denmark over the past 27 years offers us some insights. … READ MORE …

Filed under: Diagnosis, Risk | Tagged: , , , , , | Leave a Comment »

Diagnosis of BPH not a risk factor for prostate cancer

Posted on May 11, 2011 by Sitemaster

A re-analysis of data from patients enrolled in the Prostate Cancer Prevention Trial (PCPT) has now provided “the strongest evidence to date” that a diagnosis of symptomatic benign prostatic hyperplasia (BPH) is not associated with any increase in risk for prostate cancer. … READ MORE …

Filed under: Diagnosis, Risk | Tagged: , , , | Leave a Comment »

Does prostatic inflammation lead to later prostate cancer?

Posted on May 6, 2011 by Sitemaster

A question that comes up all the time is whether there is any direct (i.e., cause and effect) association between prostate “inflammation” and a subsequent diagnosis of prostate cancer. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , , , | Leave a Comment »

All the prostate cancer news for Friday, August 8

Posted on August 8, 2008 by Sitemaster

Today’s news items all focus on issues that are closely connected to the recent and controversial  guidelines issued by the US Preventive Services Task Force:

  • The accuracy of current methods for predicting the likelihood of clinically insignificant (indolent) prostate cancer
  • The management of patients found to have incidental prostate cancer on treatment for benign prostatic hyperplasia (BPH), and
  • The risks of overtreatment of men in their 70s and 80s after a diagnosis of prostate cancer … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , , , , , , , , , , | Leave a Comment »

Follow

Get every new post delivered to your Inbox.

Join 827 other followers